Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37


An Easy and Reliable Strategy for Making Type I Interferon Signature Analysis Comparable among Research Centers.

Pin A, Monasta L, Taddio A, Piscianz E, Tommasini A, Tesser A.

Diagnostics (Basel). 2019 Sep 4;9(3). pii: E113. doi: 10.3390/diagnostics9030113.


Familial hypogammaglobulinemia with high RTE and naïve T lymphocytes.

Piscianz E, Conversano E, Bianco AM, Faletra F, Tommasini A, Valencic E.

Inflamm Res. 2019 Nov;68(11):901-904. doi: 10.1007/s00011-019-01277-1. Epub 2019 Aug 29.


Tregs and Th17 lymphocytes in human DYRK1A haploinsufficiency.

Valencic E, Piscianz E, Sirchia F, Tommasini A, Faletra F, Todaro F, Spinelli AM, Badolato R.

Immunol Lett. 2019 Oct;214:52-54. doi: 10.1016/j.imlet.2019.08.003. Epub 2019 Aug 20. No abstract available.


Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism?

Piscianz E, Vecchi Brumatti L, Tommasini A, Marcuzzi A.

Neural Regen Res. 2019 Apr;14(4):582-587. doi: 10.4103/1673-5374.247441. Review.


The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases.

Bernardi S, Marcuzzi A, Piscianz E, Tommasini A, Fabris B.

Int J Mol Sci. 2018 Dec 14;19(12). pii: E4058. doi: 10.3390/ijms19124058. Review.


Neuronal Dysfunction Associated with Cholesterol Deregulation.

Marcuzzi A, Loganes C, Valencic E, Piscianz E, Monasta L, Bilel S, Bortul R, Celeghini C, Zweyer M, Tommasini A.

Int J Mol Sci. 2018 May 19;19(5). pii: E1523. doi: 10.3390/ijms19051523.


Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency.

Valencic E, Grasso AG, Conversano E, Lucafò M, Piscianz E, Gregori M, Conti F, Cancrini C, Tommasini A.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2165-2167. doi: 10.1016/j.jaip.2018.02.029. Epub 2018 Mar 3. No abstract available.


Type I interferon-mediated autoinflammation due to DNase II deficiency.

Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, Beitz B, Bondet V, Cagnard N, Duffy D, Dussiot M, Frémond ML, Gattorno M, Guillem F, Kitabayashi N, Porcheray F, Rieux-Laucat F, Seabra L, Uggenti C, Volpi S, Zeef LAH, Alyanakian MA, Beltrand J, Bianco AM, Boddaert N, Brouzes C, Candon S, Caorsi R, Charbit M, Fabre M, Faletra F, Girard M, Harroche A, Hartmann E, Lasne D, Marcuzzi A, Neven B, Nitschke P, Pascreau T, Pastore S, Picard C, Picco P, Piscianz E, Polak M, Quartier P, Rabant M, Stocco G, Taddio A, Uettwiller F, Valencic E, Vozzi D, Hartmann G, Barchet W, Hermine O, Bader-Meunier B, Tommasini A, Crow YJ.

Nat Commun. 2017 Dec 19;8(1):2176. doi: 10.1038/s41467-017-01932-3.


Reappraisal of Antimalarials in Interferonopathies: New Perspectives for Old Drugs.

Piscianz E, Cuzzoni E, Sharma R, Tesser A, Sapra P, Tommasini A.

Curr Med Chem. 2018;25(24):2797-2810. doi: 10.2174/0929867324666170911162331. Review.


Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage.

Loganes C, Lega S, Bramuzzo M, Vecchi Brumatti L, Piscianz E, Valencic E, Tommasini A, Marcuzzi A.

Nutrients. 2017 Jun 6;9(6). pii: E578. doi: 10.3390/nu9060578.


Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease.

Loganes C, Pin A, Naviglio S, Girardelli M, Bianco AM, Martelossi S, Tommasini A, Piscianz E.

World J Gastroenterol. 2016 Nov 7;22(41):9117-9126.


Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes.

Piscianz E, Candilera V, Valencic E, Loganes C, Paron G, De Iudicibus S, Decorti G, Tommasini A.

Mol Med Rep. 2016 Jul;14(1):574-82. doi: 10.3892/mmr.2016.5263. Epub 2016 May 13.


Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology.

Marcuzzi A, Piscianz E, Zweyer M, Bortul R, Loganes C, Girardelli M, Baj G, Monasta L, Celeghini C.

Int J Mol Sci. 2016 Mar 11;17(3):365. doi: 10.3390/ijms17030365.


Putative modifier genes in mevalonate kinase deficiency.

Marcuzzi A, Vozzi D, Girardelli M, Tricarico PM, Knowles A, Crovella S, Vuch J, Tommasini A, Piscianz E, Bianco AM.

Mol Med Rep. 2016 Apr;13(4):3181-9. doi: 10.3892/mmr.2016.4918. Epub 2016 Feb 22.


Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway.

Marcuzzi A, Piscianz E, Loganes C, Vecchi Brumatti L, Knowles A, Bilel S, Tommasini A, Bortul R, Zweyer M.

Int J Mol Sci. 2015 Dec 30;17(1). pii: E47. doi: 10.3390/ijms17010047. Review.


To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies.

Marcuzzi A, Piscianz E, Valencic E, Monasta L, Vecchi Brumatti L, Tommasini A.

Int J Mol Sci. 2015 Sep 7;16(9):21277-93. doi: 10.3390/ijms160921277. Review.


Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency.

Tricarico PM, Piscianz E, Monasta L, Kleiner G, Crovella S, Marcuzzi A.

Apoptosis. 2015 Aug;20(8):1048-55. doi: 10.1007/s10495-015-1139-8.


Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype.

Lougaris V, Faletra F, Lanzi G, Vozzi D, Marcuzzi A, Valencic E, Piscianz E, Bianco A, Girardelli M, Baronio M, Loganes C, Fasth A, Salvini F, Trizzino A, Moratto D, Facchetti F, Giliani S, Plebani A, Tommasini A.

Clin Immunol. 2015 Jul;159(1):33-6. doi: 10.1016/j.clim.2015.04.014. Epub 2015 May 1. No abstract available.


Knockdown of MVK does not lead to changes in NALP3 expression or activation.

Celsi F, Piscianz E, Romano M, Crovella S.

J Inflamm (Lond). 2015 Jan 31;12:7. doi: 10.1186/s12950-015-0048-5. eCollection 2015.


The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias.

Athanasakis E, Melloni E, Rigolin GM, Agnoletto C, Voltan R, Vozzi D, Piscianz E, Segat L, Dal Monego S, Cuneo A, Secchiero P, Zauli G.

Oncotarget. 2014 Dec 30;5(24):12635-45.

Supplemental Content

Loading ...
Support Center